All Menu Shortcuts Main Contants Shortcuts

Faculty

Faculty Directory

Sang Myung WOO

Name
Sang Myung WOO, MD., PhD.(adjunct professor)
Faculty Appointment
(title, department)
Professor, Department of Cancer Biomedical Science, NCC-GCSP
Staff Physician, Center for Liver Cancer
Area of Expertise
diagnosis and treatment of pancreato-biliary malignancy and its translational research
E-mail
wsm@ncc.re.kr
Work Experience
1998 – 1999 Medical Internship, Seoul National University Hospital, Korea
1999 – 2003 Residency in Internal Medicine, Seoul National University Hospital, Korea
2003 – 2006 Medical Officer in the Republic of Korea Air force
2006 – 2008 Research Fellow, Department of Internal Medicine and Liver Research
Institute, Seoul National University College of Medicine, Korea
2008- Present Staff Physician, Center for Liver Cancer, National Cancer Center,Korea
2013-2014 Visiting Scholar, Department of Pathology, School of Medicine, UC San Diego
2014- Present Senior Scientist, Liver and Pancreatobiliary branch, Division of Translational & Clinical Research I, Research Institute, National Cancer Center,Korea
Educational Background
1998 M.D., Seoul National University College of Medicine, Korea
2008 M.S., Seoul National University, Korea
2013 Ph.D., Dongguk University, Korea
As a gastroenterologist, I perform therapeutic endoscopies as well as administer medical treatments, such as chemotherapy. My main interests are diagnosis and treatment of pancreato-biliary malignancy and its translational research.
Research Interests (Please place in paragraph form)
Member, SWOG (2012–present)
International Collaboration
Achievements
2022 SCI-E Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population?based study: SCIENTIFIC REPORTS. :~ (4.38)

2022 SCI-E Proton Beam Therapy for Treatment-Naive Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade: CANCERS. 14(18):4445~ (6.575)

2022 SCI-E Percutaneous transhepatic treatment for biliary stricture after duct-to-duct biliary anastomosis in living donor liver transplantation: a 9-year single-center experience: EUROPEAN RADIOLOGY. 32(14):2414~2425 (7.034)

2022 SCI-E Establishment of Patient-derived Preclinical Models for Invasive Papillary Cholangiocarcinoma: ANTICANCER RESEARCH. 42(1):599~608 (2.48)

2021 SCI-E Plasma complement C7 as a target in non-small cell lung cancer patients to implement 3P medicine strategies: EPMA JOURNAL. 12:629~645 (6.543)

2021 SCI-E Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study: CANCERS. 13(21):5466~ (6.639)

2021 SCI-E RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin: JOURNAL OF CLINICAL MEDICINE. 10(20):4652~ (4.242)

2021 SCI-E Comparison of the Clinical Features and Outcomes of Gallbladder Neuroendocrine Carcinoma with Those of Adenocarcinoma: A Propensity Score-Matched Analysis: CANCERS. 13(18):4713~ (6.639)

2021 SCI-E Role of adjuvant radiotherapy in extrahepatic bile duct cancer: a multicenter retrospective study (Korean Radiation Oncology Group 18-14): EUROPEAN JOURNAL OF CANCER. 157:31~39 (9.162)

2021 SCI-E Extraluminal Recanalization for Biliary Duct-to-Duct Anastomotic Obstruction After Living Donor Liver Transplantation: Experience in Eight Patients: CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. 44(8):1266~1272 (2.74)

2021 SCI-E Survival in untreated hepatocellular carcinoma: A national cohort study: PLOS ONE. 16(2):e0246143~ (3.24)

2021 SCI-E Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse: THERANOSTICS. 11(7):3472~3488 (11.556)

2020 SCI-E Efficacy and feasibility of proton beam radiotherapy using the simultaneous integrated boost technique for locally advanced pancreatic cancer: SCIENTIFIC REPORTS. 10(1):21712~ (3.998)

2020 SCI-E Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: A multicenter nationwide study: PANCREATOLOGY. S1424-3903(20):30849~8 (3.629)

2020 SCI-E Efficacy of an internal anchoring plastic stent to prevent migration of a fully covered metal stent in malignant distal biliary strictures: a randomized controlled study: ENDOSCOPY. Online:Published (7.341)

2020 SCI-E ATP Production Relies on Fatty Acid Oxidation Rather than Glycolysis in Pancreatic Ductal Adenocarcinoma: CANCERS. 12(9):2477~ (6.126)

2020 SCI-E Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling: CELLS. 9(9):2013~ (4.366)

2020 SCI-E Discrimination of ascitic fluid infection inmalignant ascites by polymorphonuclear neutrophil ratio and count: Investigating the validity of count ≥250/mm3 as the one-size-fits-all criterion: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. Online:Published (2.012)

2020 SCI-E Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer (K-PaC) Registry: AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. Online:Published (1.907)

2020 SCI-E Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study: JOURNAL OF CLINICAL MEDICINE. Online:Published (3.303)

2020 SCI-E Gemcitabine Plus Cisplatin Chemotherapy Prolongs the Survival in Advanced Hilar Cholangiocarcinoma A Large Multicenter Study: AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. Online:Published (1.907)

2020 SCI-E Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma: FRONTIERS IN ONCOLOGY. 10:542~ (4.848)

2020 SCI-E Use of Gadoxetic Acid-enhanced Liver MRI and Mortality in More than 30?000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis: RADIOLOGY. 295(1):114~124 (7.931)

2019 SCI-E Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery: Pancreatology. Online:Published (3.241)

2019 SCI-E Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples: Frontiers in oncology. 9:875~ (4.137)

2019 SCI Intraductal placement of non-flared fully covered metallic stent for refractory anastomotic biliary strictures after living donor liver transplantation: Long-term results of prospective multicenter trial: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. Online:Published (3.632)

2019 SCI Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma: SCIENTIFIC REPORTS. 9(1):11770~11770 (4.011)

2019 SCI-E Predicting lymph node metastasis in pancreatobiliary cancer with magnetic resonance imaging: A prospective analysis: EUROPEAN JOURNAL OF RADIOLOGY. 116:1~7 (2.948)

2019 SCI-E Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment: GUT AND LIVER. 13(6):683~689 (2.968)

2019 기타 Endoscopic management of duodenal perforations caused by migrated biliary plastic stents: Endoscopy International Open. 7(6):e792~e795 (0)

2019 SCI-E Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma: European Journal of Surgical Oncology. Online:Published (3.379)

2019 SCI-E Cytopathological results of initial endoscopic ultrasound-guided fine needle aspiration for primary mass and prognosis in pancreatic cancer patients: Cytopathology. 30(2):173~178 (1.376)

2019 SCI-E Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma?: CANCERS. 11(2):E230~E230 (6.162)

2019 SCI-E Effect of Early Management on Pain and Depression in Patients with Pancreatobiliary Cancer: A Randomized Clinical Trial: CANCERS. 11(1):E79~E79 (6.162)

2018 기타 Somatic Mutations from Whole Exome Sequencing Analysis of the Patients with Biliary Tract Cancer: GENOMICS & INFORMATICS. 16(4):e35~e35 (0)

2018 SCI-E Prospective Multicenter Study on the Challenges Inherent to Using Large Cell-Type Stents for Bilateral Stent-in-Stent Placement in Patients with Inoperable Malignant Hilar Biliary Obstruction: Gut and Liver. 12(6):722~727 (2.849)

2018 기타 Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boostintensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer: Radiation Oncology Journal. 36(3):200~209 (0)

2018 SCI-E Individualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcare: EPMA Journal. 9(3):287~297 (3.9)

2018 SCI-E Incidence of Diabetes After Cancer Development : A Korean National Cohort Study: JAMA oncology. 4(8):1099~1105 (20.871)

2018 SCI-E Effectiveness and Safety of Simultaneous Integrated Boost-Proton Beam Therapy for Localized Pancreatic Cancer: Technology in cancer research & treatment. 17:1~9 (1.646)

2018 기타 3D Culture Protocol for Testing Gene Knockdown Efficiency and Cell Line Derivation: Bio-protocol. 8(11):e2874~e2874 (0)

2018 SCI-E Favorable glycemic response after pancreatoduodenectomy in both patients with pancreatic cancer and patients with non-pancreatic cancer: Medicine. 97(18):e0590~e0590 (2.028)

2018 SCI Prognostic implications of multiplex detection of KRAS mutations in cell-free DNA from patients with pancreatic ductal adenocarcinoma: Clinical chemistry. 64(4):726~734 (8.636)

2017 SCI-E Proximal Resection Margins: More Prognostic than Distal Resection Margins in Patients Undergoing Hilar Cholangiocarcinoma Resection: Cancer research and treatment. 50(4):1106~1113 (3.772)

2017 SCI Clinical multi-omics strategies for the effective cancer management: Journal of Proteomics. 188:97~106 (3.914)

2017 SCI-E Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer.: Cancer Research and Treatment. 50(3):883~893 (3.772)

2017 SCI-E Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma: Oncotarget. 9(3):4034~4043 (5.168)

2017 SCI-E Reduced levels of N’-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival: Oncotarget. 8(68):112598~112609 (5.168)

2017 SCI-E DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study: oncotarget. 8(46):81394~81404 (5.168)

2017 SCI-E Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study: Cancer Research and Treatment. 49(4):1022~1032 (3.772)

2017 SCI Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea.: Cancer Chemother Pharmacol. 80:799~805 (2.737)

2017 기타 Effect of Capecitabine plus Oxaliplatin for Advanced Adenocarcinoma of Ampulla of Vater: The Korean Journal of Pancreas and Biliary Tract. 22:127~133 ()

2017 기타 Chemotherapy for Biliary Tract Cancer: 대한소화기학회지. 69:172~176 ()

2017 SCI-E Impact of Celiac Plexus Neurolysis on Survival in Patients with Unresectable Pancreatic Cancer: A Retrospective, Propensity Score Matching Analysis: Pain Physician. 20(3):E357~E365 (2.84)

2016 SCI Clinicopathological characteristics of biliary neuroendocrine neoplasms: a multicenter study.: Scand J Gastroenterol. 52(4):437~441 (2.199)

2016 SCI Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis: Radiotherapy and Oncology. 122(1):122~129 (4.817)

2016 SCI-E Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial: Pancreatology. 16(6):1099~1105 (2.406)

2016 SCI Reintervention for occluded metal stent in malignant bile duct obstruction: a prospective randomized trial comparing covered and uncovered metal stent: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 31911):1901~1907 (3.322)

2016 SCI Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumor- A Retrospective Nationwide Multicenter Study in South Korea: Pancreas. 45(7):941~946 (2.738)

2016 SCI-E Development and Validation of a Prediction Model to Estimate Individual Risk of Pancreatic Cancer: PloS one. 11(1):e0146473~e0146473 (3.057)

2015 SCI-E Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection: Disease Markers. 2015:298985~298985 (1.562)

2015 SCI Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma: Strahlentherapie und Onkologie. 191(11):835~844 (2.914)

2015 SCI Cytidine Deaminase as a Molecular Predictor of Gemcitabine Response in Patients with Biliary Tract Cancer: Oncology. 89(6):345~350 (2.422)

2015 SCI-E Small Cell Versus Large Cell-Sized Metal Stent in Endoscopic Bilateral Stent-in-Stent Placement for Malignant Hilar Biliary Obstruction1: Digestive endoscopy. 27(6):692~699 (2.058)

2015 SCI-E Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma.: Cancer research and treatment. 47(1):34~45 (3.318)

2014 SCI Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma: Strahlentherapie und Onkologie. 190(10):882~890 (2.733)

2014 SCI Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.: Strahlentherapie und Onkologie. 190(9):806~814 (2.733)

2014 기타 Pneumopericardium Caused by Gastropericardial Fistula after Use of NSAIDs in a Patient with Acute Pericarditis and Gastric Cancer: 대한내과학회지. 86(4):489~493 (0)

2014 SCI Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area: Journal of Gastroenterology and Hepatology. 29(4):820~829 (3.627)

2014 SCI Efficacy of argon plasma coagulation in the treatment of radiation-induced hemorrhagic gastroduodenal vascular ectasia: Scandinavian Journal of Gastroenterology. 49(2):238~245 (2.329)

2014 SCI 5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Advanced Pancreatic Cancer Who Have Progressed on Gemcitabine-Based Therapy: Chemotherapy. 59(4):273~279 (1.554)

2013 SCI Gemcitabine plus Cisplatin versus Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Cohort Study: Chemotherapy. 59(3):232~238 (1.554)

2013 SCI-E Outcomes of Concurrent Chemoradiotherapy versus Chemotherapy Alone for Advanced-stage Unresectable Intrahepatic Cholangiocarcinoma: Radiation Oncology. 21(8):292~292 (2.107)

2013 SCI Worse Outcome of Sorafenib Therapy Associated with Ascites and Child-Pugh Score in Advanced Hepatocellular Carcinoma1: Journal of Gastroenterology and Hepatology. 28(11):1756~1761 (3.325)

2013 SCI-E A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer: Gut and Liver. 7(5):594~598 (1.314)

2013 기타 Changes in Dietary Intake, Body Weight, Nutritional Status, and Metabolic Rate in a Pancreatic Cancer Patient: Clinical Nutrition Research. 2:154~158 (0)

2013 SCI-E Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer: Radiation Oncology. 8(1):160~160 (2.107)

2013 SCI The optimal duration of preoperative biliary drainage for periampullary tumors that cause severe obstructive jaundice: The American Journal of Surgery. 206(1):40~46 (2.516)

2013 SCI Comparison of uncovered and covered stents for the treatment of malignant duodenal obstruction caused by pancreaticobiliary cancer: Surgical Endoscopy. 27(6):2031~2039 (3.427)

2013 SCI Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas: The Scandinavian Journal of Gastroenterology. 48(5):610~616 (2.156)

2013 SCI Risk of Pancreatic Cancer in Relation to ABO Blood Group and Hepatitis C Virus Infection in Korea: A Case-Control Study: Journal of Korean Medical Science. 28(2):247~251 (1.249)

2012 SCI-E Surgical outcome of pancreatic cancer using radical antegrade modular pancreatosplenectomy procedure: World journal of gastroenterology. 18(39):5595~5600 (2.471)

2012 기타 New Strategy in Cases of Failed Endoscopic Intervention of Biliary Strictures after Living Donor Liver Transplantation: Percutaneous Transhepatic Biliary Stent Insertion and Subsequent Endoscopic Treatment: The Journal of the Korean Society for Transplantation. 26(3):188~195 (0)

2012 SCI Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Single-Center Study: Chemotherapy. 58(3):225~232 (1.816)

2012 SCI Patterns of Initial Disease Recurrence after Resection of Biliary Tract Cancer: Oncology. 83(2):83~90 (2.267)

2012 SCI-E T-category reflects the histopathologic characteristics of gallbladder cancer: European Journal of Surgical Oncology. 38(6):537~542 (2.499)

2012 SCI Phase II Study of Concurrent Transarterial Chemoembolization and Sorafenib for Patients with Unresectable Hepatocellular Carcinoma: Journal of hepatology.. 56(6):1336~1342 (9.264)

2012 SCI Multiple Primary Malignant Neoplasms in Pancreatic Cancer Patients: A Single-Center Experience in Korea: Pancreas. 41(4):648~649 (2.386)

2012 기타 Bouveret’s syndrome: a case report and a review of the literature: Korean J Hepatobiliary Pancreat Surg. 16:84~87 (0)

2012 SCI Prostate Stem Cell Antigen, a Presumable Organ-Dependent Tumor Suppressor Gene, Is Down-Regulated in Gallbladder Carcinogenesis: Genes, Chromosomes & Cancer. 51(1):30~41 (3.306)

2012 SCI Clinical Significance of Portal-Superior Mesenteric Vein Resection in Pancreatoduodenectomy for Pancreatic Head Cancer: Pancreas. 41(1):102~106 (2.386)

2011 SCI Severity and Timing of Progression Predict Refractoriness to Transarterial Chemoembolization in Hepatocellular Carcinoma: J Gastroenterol Hepatol. 27(6):1051~1056 (2.865)

2011 SCI Role of Adjuvant Chemoradiotherapy for Resected Extrahepatic Biliary Tract Cancer.: International journal of radiation oncology, biology, physics.. 81:853~859 (4.503)

2011 SCI CA 19-9 Level as Indicator of Early Distant Metastasis and Therapeutic Selection in Resected Pancreatic Cancer: International Journal of Radiation Oncology, Biology, Physics. 81:743~748 (4.503)

2011 SCI Clinical features of 20 patients with curatively resected biliary neuroendocrine tumours: Digestive and Liver Disease. 43(12):965~970 (2.805)

2011 SCI Pretreatment Carbohydrate Antigen 19-9 Level Indicates Tumor Response, Early Distant Metastasis, Overall Survival, and Therapeutic Selection in Localized and Unresectable Pancreatic Cancer.: International journal of radiation oncology, biology, physics.. 81:623~630 (4.503)

2011 SCI Effects and Mechanisms of the Combination of Suberoylanilide Hydroxamic Acid and Bortezomib on the Anticancer Property of Gemcitabine in Pancreatic Cancer.: Pancreas. 40(6):966~973 (2.607)

2011 SCI-E Clinical and Virological Responses to Clevudine Therapy of Hepatocelluar Carcinoma Patients with Chronic Hepatitis B: Gut and Liver. 5(1):82~87 (0.219)

2010 SCI-E Endoscopic management of occluded metal biliary stents: Metal versus 10F plastic stents: World Journal of Gastroenterology. 16(42):5347~5352 (2.092)

2010 SCI-E Appropriate diagnosis of biliary cystic tumors: comparison with atypical hepatic simple cysts: European Journal of Gastroenterology & Hepatology. 22:989~996 (1.662)

2010 SCI Adjuvant Chemoradiation Therapy in Gallbladder Cancer: Journal of Surgical Oncology. 102(1):87~93 (2.502)

2010 SCI Survival Analysis of Intrahepatic Cholangiocarcinoma After Resection: Annals of Surgical Oncology. 17(7):1823~1830 (4.13)

2010 기타 Isolated pancreatic metastasis of hepatocellular carcinoma after curative resection: World Journal of Gastrointestinal Oncology. 2(4):209~212 (0)

2009 SCI A comparison of metal and plastic stents for the relief of jaundice in unresectable malignant biliary obstruction in Korea: an emphasis on cost-effectiveness in a country with a low ERCP cost.: Gastrointestinal endoscopy. 70(2):284~289 (7.367)

2009 SCI A comparison of the Niti-D biliary uncovered stent and the uncovered Wallstent in malignant biliary obstruction.: Gastointestinal endoscopy. 70:45~51 (7.367)

2009 SCI Branch duct intraductal papillary mucinous neoplasms in a retrospective series of 190 patients: British Journal of Surgery. 96:405~411 (4.304)

2008 SCI Feasibility of endoscopic papillectomy in early stage ampulla of Vater cancer: Journal of Gastroenterology and Hepatology. Online:Published (1.673)

2008 SCI Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.: Annals of Surgical Oncology. 15:3193~3198 (3.917)

2008 SCI Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial: Pancreas. 37:366~370 (2.3)

2008 SCI Prognosis of Invasive Intraductal Papillary Mucinous Neoplasm.: Pancreas. 37:333~334 (2.3)

2008 기타 Pancreatic endocrine tumors: clinical manifestations and predictive factors associated with survival: Korean Journal of Gastroenterology. 52:171~178 ()

2008 SCI Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer: Cancer Letters. 259:39~49 (3.398)

2008 SCI Does endoscopic sphincterotomy reduce the recurrence rate of cholangitis in patients with cholangitis and suspected of a common bile duct stone not detected by ERCP?: Gastrointestinal Endoscopy. 67:51~57 (5.888)

2008 SCI Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.: Pancreas. 36:50~55 (2.3)

2008 SCI Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.: Annals of surgical oncology. 14:3195~3201 (3.329)

2008 SCI Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer.: Pancreas. 35:9~15 (2.121)

2008 SCI Outcomes of Cystic Lesions in the Pancreas After Extended Follow-up.: Digestive diseases and sciences. 52:2653~2659 (1.448)

2004 SCI Cyst fluid analysis for the differential diagnosis of pancreatic cysts: Diagnostic cytopathology. 31:100~105 (1.092)